French President Emmanuel Macron unveiled Institut Pasteur de São Paulo (IPSP) during a visit to the city on 27 March. Located on the campus of the University of São Paulo (USP) in a 2,000-square-meter building, the newest member of the Pasteur Network has the capacity to… Read More
Recursion has announced plans to open a new office in June 2024. The site will provide Recursion and Valence Labs, the company’s artificial intelligence (AI) research engine, with access to European talent and a life science ecosystem from which to work. Chris Gibson, Co-founder and CEO… Read More
The University of Glasgow and Kadans Science Partner, supported by Scottish Enterprise, have announced plans to construct a new Health Innovation Hub in Govan in Glasgow. It is hope that the new centre, which is due for completion in summer 2025, will set the stage for… Read More
Gene delivery technologies company VectorBuilder has opened a new office in Edinburgh, hoping to bolster its presence in the United Kingdom. The new location is part of Edinburgh Technopole, a Pioneer Group in Midlothian Science Zone. “When it comes to published scientific research, the UK is… Read More
Gate Neurosciences has increased its R&D capabilities with new expanded research operations and lab facilities in Evanston, Illinois. The company hopes to further build the translational biomarker data package supporting its NMDA receptor modulator portfolio and advance foundational mechanism insights behind its synaptic function-enhancing molecules. Read More
GenScript USA has expanded its global current Good Manufacturing Practices (cGMP) single-guide RNA (sgRNA) manufacturing capabilities to meet the growing demand for cell and gene therapies. The 400,000 square-foot cGMP facility enables gene and cell therapy R&D programmes to advance IND filings and clinical trials. The company’s… Read More
Merck has invested more than €290 million in its biosafety testing capacity at Rockville, Maryland, in the US. The company says the investment will significantly increase the company’s ability to conduct biosafety testing and analytical development services, critical to the drug development and commercialisation process. … Read More
Expansions to laboratory space throughout the drug discovery industry can only be a good thing – new centres of innovation will bring more space to grow, more advanced technologies, improved sustainability and new employment opportunities. While there have been a significant number of new facilities built in the US,… Read More
Bioanalytical and CMC testing services provider Alliance Pharma will open a bioanalytical laboratory in Brisbane Australia, the company has announced. Alliance expects the facility to be fully operational by November 2022, where it enable the company to transfer methods and maintain continuous project management across its global… Read More
